Polskie Radio covers the next wave of weight loss drugs, with retatrutide and CagriSema named. Few details were available beyond the topic itself.
Recap by typeshit. Full story at www.polskieradio.pl.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
A clinician reminds patients on GLP-1 medications that their bodies are not flawed or broken. A short brand post with a body-positive message.
Her view is that quicker loss on retatrutide doesn't automatically mean improved metabolic health. It's a short opinion post with no new data behind it.
Loading…